Literature DB >> 8574210

Potential drug--drug interactions in 5,125 mostly elderly out-patients in Gothenburg, Sweden.

L Bergendal1, A Friberg, A Schaffrath.   

Abstract

Of 5,125 mostly elderly out-patients, average age 78.2 years, 1,594 (31%) had at least one interacting drug combination according to the Swedish National Formulary. On average, each patient with drug-drug interactions (DDIs) had 1.6 DDIs. There was no difference in the sex or age between those having DDIs and those without. However, patients with one or more DDIs used a significantly larger number of drugs than those without DDIs, on average 8.1 versus 5.2. This significant difference was independent of age and sex. When classified for clinical significance according to the handbook "Drug Interactions and Updates" by Hansten and Horn, 155 (3%) patients had interactions of 'major clinical significance'. The most common were interactions between beta-adrenergic blockers and antidiabetics, followed by potassium-sparing diuretics and potassium, and carbamazepine and dextropropoxyphene. The methodology allows us to screen routinely for DDIs and to plan further studies with emphasis on clinical outcome.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8574210     DOI: 10.1007/bf01879709

Source DB:  PubMed          Journal:  Pharm World Sci        ISSN: 0928-1231


  16 in total

1.  Drug related admissions to medical wards: a population based survey.

Authors:  J Hallas; L F Gram; E Grodum; N Damsbo; K Brøsen; T Haghfelt; B Harvald; J Beck-Nielsen; J Worm; K B Jensen
Journal:  Br J Clin Pharmacol       Date:  1992-01       Impact factor: 4.335

Review 2.  Drug interactions that matter. A critical reappraisal.

Authors:  G T McInnes; M J Brodie
Journal:  Drugs       Date:  1988-07       Impact factor: 9.546

3.  Comparison of propranolol, metoprolol, and acebutolol on insulin-induced hypoglycaemia.

Authors:  R J Newman
Journal:  Br Med J       Date:  1976-08-21

4.  Documenting drug-drug interactions in ambulatory patients.

Authors:  G W Mitchell; W F Stanaszek; N B Nichols
Journal:  Am J Hosp Pharm       Date:  1979-05

5.  Drug reactions and interactions in the elderly patient.

Authors:  P F D'Arcy
Journal:  Drug Intell Clin Pharm       Date:  1982-12

6.  Drug interactions in the elderly.

Authors:  J F Kurfees; R L Dotson
Journal:  J Fam Pract       Date:  1987-11       Impact factor: 0.493

Review 7.  Drug-related hospital admissions.

Authors:  T R Einarson
Journal:  Ann Pharmacother       Date:  1993 Jul-Aug       Impact factor: 3.154

Review 8.  Epidemiology of drug-drug interactions as a cause of hospital admissions.

Authors:  C A Jankel; L K Fitterman
Journal:  Drug Saf       Date:  1993-07       Impact factor: 5.606

9.  Acebutolol, atenolol, and propranolol and metabolic responses to acute hypoglycaemia in diabetics.

Authors:  S P Deacon; A Karunanayake; D Barnett
Journal:  Br Med J       Date:  1977-11-12

10.  Drug interaction exposures in an ambulatory Medicaid population.

Authors:  M J Jinks; P D Hansten; J L Hirschman
Journal:  Am J Hosp Pharm       Date:  1979-07
View more
  20 in total

Review 1.  ["Clinically significant" new drug interactions].

Authors:  U Fuhr
Journal:  Med Klin (Munich)       Date:  1999-02-15

Review 2.  Optimal medication use in elders. Key to successful aging.

Authors:  M Monane; S Monane; T Semla
Journal:  West J Med       Date:  1997-10

Review 3.  Potential determinants of drug-drug interaction associated dispensing in community pharmacies.

Authors:  Matthijs L Becker; Marjon Kallewaard; Peter W J Caspers; Tom Schalekamp; Bruno H C Stricker
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

4.  Clinical relevance of drug-drug interactions : a structured assessment procedure.

Authors:  Eric N van Roon; Sander Flikweert; Marianne le Comte; Pim N J Langendijk; Wilma J M Kwee-Zuiderwijk; Paul Smits; Jacobus R B J Brouwers
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

5.  Management of potential drug interactions in community pharmacies: a questionnaire-based survey in Switzerland.

Authors:  Jörg Indermitte; Laura Erba; Marianne Beutler; Rudolf Bruppacher; Walter E Haefeli; Kurt E Hersberger
Journal:  Eur J Clin Pharmacol       Date:  2007-01-11       Impact factor: 2.953

6.  Detection of potential drug interactions - a model for a national pharmacy register.

Authors:  Bengt Astrand; Emelie Astrand; Karolina Antonov; Göran Petersson
Journal:  Eur J Clin Pharmacol       Date:  2006-07-29       Impact factor: 2.953

7.  Determinants of potential drug-drug interaction associated dispensing in community pharmacies in the Netherlands.

Authors:  Matthijs L Becker; Peter W J Caspers; Marjon Kallewaard; Riekert J Bruinink; Nico B Kylstra; Siem Heisterkamp; Vincent de Valk; André A van der Veen; Bruno H Ch Stricker
Journal:  Pharm World Sci       Date:  2006-12-23

8.  The prevalence of potential drug-drug interactions in patients with heart failure at hospital discharge.

Authors:  Bernhard Straubhaar; Stephan Krähenbühl; Raymond G Schlienger
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

9.  Identification of severe potential drug-drug interactions using an Italian general-practitioner database.

Authors:  L Magro; A Conforti; F Del Zotti; R Leone; M L Iorio; I Meneghelli; D Massignani; E Visonà; U Moretti
Journal:  Eur J Clin Pharmacol       Date:  2007-11-09       Impact factor: 2.953

10.  Potential drug-drug interactions in prescriptions dispensed in community pharmacies in Greece.

Authors:  Anna Chatsisvili; Ioakeim Sapounidis; Georgia Pavlidou; Eudoxia Zoumpouridou; Vasileios-Alexandros Karakousis; Marios Spanakis; Lefteris Teperikidis; Ioannis Niopas
Journal:  Pharm World Sci       Date:  2010-01-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.